Mars logo

Mars

Last updated January 31, 2026
88
Innovation Areas
2,578
Inventors
20
Collaborations

Factor xi and l-citrulline modulators: MarsRecent Research Landscape

Vascular resistance and poor drug response in hyporesponders increase cardiovascular risk. This lever stabilizes nitric oxide pathways to restore endothelial function.

What technical problems is Mars addressing in Factor xi and l-citrulline modulators?

Pathological vascular tissue remodeling

(24)evidences

Impaired endothelial nitric oxide pathways and oncogenic protein signaling failures. Addressing these malfunctions restores physiological homeostasis and overcomes therapeutic resistance.

Neurodegenerative metabolic enzyme deficiency

(2)evidences

Insufficient efficacy of existing antiepileptic treatments. Improving seizure suppression reduces neurological damage and improves patient safety.

Insufficient immune system recovery

(2)evidences

Damage or permeability in the gut lining leads to systemic inflammation and pathogen entry. Restoring this barrier prevents secondary infections and chronic inflammatory responses.